Meta Health to acquire 55% stake in Jas Medical Screening Centre for $0.5 mil
As at Nov 18, the clinic has an issued and paid-up share capital of $100,000 comprising 100,000 ordinary shares.
Meta Health Limited has entered into a sale and purchase agreement for the acquisition of 55,000 shares, representing a 55% stake, in Jas Medical Screening Centre.
The sale consideration for the shares stood at $533,310, comprising $300,000 payable in cash and 23,331,000 Meta shares to be issued to the seller, Lian Ah Lek, at the issue price of 1 cent per share. Lian is the founder, director and shareholder of Jas Medical Screening Centre.
As at Nov 18, the clinic has an issued and paid-up share capital of $100,000 comprising 100,000 ordinary shares.
According to the group, the acquisition represents “a good opportunity for the group to build shareholder value and strengthen its financial position”.
On a pro forma basis, had the acquisition been completed on Jan 1, 2023, the group’s losses for the FY2023 would have stood at $8.5 million instead of a loss of $8.4 million. Loss per share would have stood at 1.24 cents, instead of a loss per share of 1.31 cents.
Shares in Meta Health 5dx closed flat at 7 cents on Nov 18.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10